Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Express Scripts
Medtronic
Moodys
Colorcon

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Zydus Pharms Usa Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA, and what generic and branded alternatives to ZYDUS PHARMS USA drugs are available?

ZYDUS PHARMS USA has sixty approved drugs.

There are seventeen tentative approvals on ZYDUS PHARMS USA drugs.

Summary for Zydus Pharms Usa
US Patents:0
Tradenames:51
Ingredients:51
NDAs:60

Drugs and US Patents for Zydus Pharms Usa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc DIPYRIDAMOLE dipyridamole TABLET;ORAL 040874-001 Jan 28, 2008 AB RX No No   Start Trial   Start Trial
Zydus Pharms Usa Inc DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 090175-002 May 10, 2011 DISCN No No   Start Trial   Start Trial
Zydus Pharms Usa Inc GABAPENTIN gabapentin TABLET;ORAL 078926-002 Feb 11, 2011 AB RX No No   Start Trial   Start Trial
Zydus Pharms Usa ATENOLOL atenolol TABLET;ORAL 076900-001 Jan 28, 2005 AB RX No No   Start Trial   Start Trial
Zydus Pharms Usa WARFARIN SODIUM warfarin sodium TABLET;ORAL 040663-006 May 30, 2006 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Boehringer Ingelheim
AstraZeneca
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.